Skip to content

Medical-device intelligence

LRG: Instrument For Auto Reader & Interpretation Of Overnight Suscept. Systems

FDA product code LRG: Instrument For Auto Reader & Interpretation Of Overnight Suscept. Systems. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
LRG
FDA device name
Instrument For Auto Reader & Interpretation Of Overnight Suscept. Systems
Device class
2
Regulation number
866.1640
Medical specialty
Microbiology
Review panel
MI

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore microbiology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

45 clearance records and 13 recall records in the covered releases, across 17 source company names and 1 product codes. Dated history runs from Mar 25, 1987 to Feb 12, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

58 matching records
Device / recordCompany in FDA recordSourceSource date
MICROSCAN MICROSTREP PLUS PANEL CEFOTAXIME (0.015 - 8 MCG/MLK063101 · LRGDade Behring, Inc.510(k)Nov 1, 2006FDA decision date
MICROSCAN MICROSTREP PLUS PANEL MEROPENEM (0.03-4MCG/ML)K063065 · LRGDade Behring, Inc.510(k)Oct 27, 2006FDA decision date
MICROSCAN MICROSTREP PLUS PANEL ERYTHROMYCIN (0.015 TO 2 MCG/ML)K062375 · LRGDade Behring, Inc.510(k)Oct 26, 2006FDA decision date
MICROSCAN MICROSTREP PLUS PANEL CEFUROXIME (0.12-8 MCG/ML)K063053 · LRGDade Behring, Inc.510(k)Oct 26, 2006FDA decision date
MICROSCAN MICROSTREP PLUS PANEL CEFTRIAXONE (0.015-8MCG/ML)K063064 · LRGDade Behring, Inc.510(k)Oct 26, 2006FDA decision date
MICROSCAN MICROSTREP PLUS PANEL TETRACYCLINE (0.006 TO 16 MCG/ML)K062923 · LRGDade Behring, Inc.510(k)Oct 13, 2006FDA decision date
MICROSCAN MICROSTREP PLUS PANEL AMPICILLIN (0.013 - 16 MCG/ML)K062927 · LRGDade Behring, Inc.510(k)Oct 12, 2006FDA decision date
MICROSCAN MICROSTREP PLUS PANEL AZITHROMYCINK062585 · LRGDade Behring, Inc.510(k)Sep 19, 2006FDA decision date
MICROSTREP PLUS PANEL AMOXICILLIN/CLAVULANIC ACIDK062596 · LRGDade Behring, Inc.510(k)Sep 19, 2006FDA decision date
MICROSCAN MICROSTREP PLUS PANEL VANCOMYCIN (0.06 - 8 MCG/ML)K062290 · LRGDade Behring, Inc.510(k)Sep 1, 2006FDA decision date
MICROSCAN MICROSTREP PLUS PANEL CHLORAMPHENICOL (1 TO 32 MCG/ML)K062293 · LRGDade Behring, Inc.510(k)Aug 24, 2006FDA decision date
MICROSCAN MICROSTREP PLUS PANELK061872 · LRGDade Behring, Inc.510(k)Aug 23, 2006FDA decision date
MICROSCAN DRIED GRAM-POSITIVE MIC/COMBO PANELS WITH ERYTHROMYCIN (0.25 - 16UG/ML)K062179 · LRGDade Behring, Inc.510(k)Aug 23, 2006FDA decision date
MICROSCAN MICROSTREP PLUS PANELK062276 · LRGDade Behring, Inc.510(k)Aug 23, 2006FDA decision date
SENSITITRE 18-24 HOURS SUSCEPTIBILITY PLATESK053243 · LRGTrek Diagnostic Systems, Inc.510(k)Jan 20, 2006FDA decision date
MICROSCAN DRIED GRAM-POSITIVE MIC/COMBO PANELS WITH ERYTHROMYCINK050043 · LRGDade Behring, Inc.510(k)Mar 29, 2005FDA decision date
MICROSCAN DRIED GRAM NEGATIVE MIC/COMBO PANELS AMOXICILLIN/K. CLAVULANATEK050585 · LRGDade Behring, Inc.510(k)Mar 18, 2005FDA decision date
MICROSCAN DRIED GRAM-POSITIVE MIC/COMBO PANELS WITH DAPTOMYCIN (0.03 - 16 MCG/ML)K043545 · LRGDade Behring, Inc.510(k)Feb 17, 2005FDA decision date
MICROSCAN SYNERGIES PLUS GRAM-NEGATIVE MIC/COMBO PANELSK041150 · LRGDade Behring, Inc.510(k)Jul 22, 2004FDA decision date
MICROSCAN DRIED GRAM-NEGATIVE MIC/COMBO PANELS (GEMIFLOXACIN)K033948 · LRGDade Behring, Inc.510(k)Mar 1, 2004FDA decision date
MICROSCAN DRIED GRAM NEGATIVE MIC/COMBO PANELS , ESBL SCREENK981199 · LRGDade Microscan, Inc.510(k)Nov 18, 1998FDA decision date
ALAMAR ANTIBIOTIC SUSCEPTIBILITYK941425 · LRGAlamar Biosciences Laboratory, Inc.510(k)Dec 15, 1994FDA decision date
READARK930478 · LRGAlamar Biosciences, Inc.510(k)Oct 22, 1993FDA decision date
SYNERGY SCREEN TEST, MODIFICATIONK921977 · LRGBaxter Healthcare Corp510(k)Oct 12, 1993FDA decision date
READARK925951 · LRGAlamar Biosciences Laboratory, Inc.510(k)Aug 31, 1993FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗